- Home
- HES vs IDXX Comparison
HES vs IDXX Comparison
Compare HES & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HES
- IDXX
- Stock Information
- Founded
- HES 1920
- IDXX 1983
- Country
- HES United States
- IDXX United States
- Employees
- HES N/A
- IDXX N/A
- Industry
- HES Integrated oil Companies
- IDXX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- HES Energy
- IDXX Health Care
- Exchange
- HES Nasdaq
- IDXX Nasdaq
- Market Cap
- HES 41.4B
- IDXX 34.1B
- IPO Year
- HES N/A
- IDXX 1991
- Fundamental
- Price
- HES $130.64
- IDXX $411.49
- Analyst Decision
- HES Buy
- IDXX Buy
- Analyst Count
- HES 10
- IDXX 8
- Target Price
- HES $166.86
- IDXX $523.75
- AVG Volume (30 Days)
- HES 2.3M
- IDXX 1.0M
- Earning Date
- HES 04-30-2025
- IDXX 05-01-2025
- Dividend Yield
- HES 1.53%
- IDXX N/A
- EPS Growth
- HES 100.00
- IDXX 6.06
- EPS
- HES 8.98
- IDXX 10.67
- Revenue
- HES $12,662,000,000.00
- IDXX $3,897,504,000.00
- Revenue This Year
- HES N/A
- IDXX $7.74
- Revenue Next Year
- HES $16.57
- IDXX $7.74
- P/E Ratio
- HES $14.55
- IDXX $38.57
- Revenue Growth
- HES 22.99
- IDXX 6.46
- 52 Week Low
- HES $123.79
- IDXX $356.14
- 52 Week High
- HES $163.98
- IDXX $548.88
- Technical
- Relative Strength Index (RSI)
- HES 38.27
- IDXX 50.94
- Support Level
- HES $124.34
- IDXX $398.75
- Resistance Level
- HES $131.63
- IDXX $398.73
- Average True Range (ATR)
- HES 6.40
- IDXX 17.58
- MACD
- HES -1.95
- IDXX 2.10
- Stochastic Oscillator
- HES 16.87
- IDXX 77.88
About HES Hess Corporation
Hess is an independent oil and gas producer with key assets in the Bakken Shale, Guyana, the Gulf of Mexico, and Southeast Asia. At the end of 2023, the company reported net proved reserves of 1.4 billion barrels of oil equivalent. Net production averaged 391 thousand barrels of oil equivalent per day in 2023, at a ratio of 74% oil and natural gas liquids and 26% natural gas.
About IDXX IDEXX Laboratories Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.